Empagliflozin (BI 10773) Comprehensive add-on Study in Japanese Subjects With Type 2 Diabetes Mellitus

PHASE3CompletedINTERVENTIONAL
Enrollment

1,162

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Metformin

Metformin tablets 500-2250 mg a day (twice or three times per day)

DRUG

BI 10773

BI 10773 low dose tablet once daily

DRUG

Placebo (low dose)

Placebo tablets once daily

DRUG

BI 10773

BI 10773 high dose tablet once daily

DRUG

Placebo (high dose)

Placebo tablets once daily

Trial Locations (87)

Unknown

1245.52.023 Boehringer Ingelheim Investigational Site, Adachi-ku, Tokyo

1245.52.048 Boehringer Ingelheim Investigational Site, Aki-gun, Hiroshima

1245.52.012 Boehringer Ingelheim Investigational Site, Annaka, Gunma

1245.52.087 Boehringer Ingelheim Investigational Site, Atami, Shizuoka

1245.52.008 Boehringer Ingelheim Investigational Site, Beppu, Oita

1245.52.073 Boehringer Ingelheim Investigational Site, Chiyoda-ku, Tokyo

1245.52.002 Boehringer Ingelheim Investigational Site, Chuo-ku, Tokyo

1245.52.020 Boehringer Ingelheim Investigational Site, Chuo-ku, Tokyo

1245.52.021 Boehringer Ingelheim Investigational Site, Chuo-ku, Tokyo

1245.52.031 Boehringer Ingelheim Investigational Site, Fujisawa, Kanagawa

1245.52.077 Boehringer Ingelheim Investigational Site, Fukuoka, Fukuoka

1245.52.086 Boehringer Ingelheim Investigational Site, Hadano, Kanagawa

1245.52.037 Boehringer Ingelheim Investigational Site, Hamamatsu, Shizuoka

1245.52.046 Boehringer Ingelheim Investigational Site, Himeji, Hyogo

1245.52.047 Boehringer Ingelheim Investigational Site, Hiroshima, Hiroshima

1245.52.051 Boehringer Ingelheim Investigational Site, Imabari, Ehime

1245.52.016 Boehringer Ingelheim Investigational Site, Iruma,Saitama

1245.52.033 Boehringer Ingelheim Investigational Site, Isehara, Kanagawa

1245.52.011 Boehringer Ingelheim Investigational Site, Isesaki, Gunma

1245.52.045 Boehringer Ingelheim Investigational Site, Izumisano,Osaka

1245.52.088 Boehringer Ingelheim Investigational Site, Kamakura, Kanagawa

1245.52.072 Boehringer Ingelheim Investigational Site, Kamakura,Kanagawa

1245.52.034 Boehringer Ingelheim Investigational Site, Kanazawa, Ishikawa

1245.52.058 Boehringer Ingelheim Investigational Site, Kanoya, Kagoshima

1245.52.019 Boehringer Ingelheim Investigational Site, Kashiwa, Chiba

1245.52.039 Boehringer Ingelheim Investigational Site, Kasugai, Aichi

1245.52.027 Boehringer Ingelheim Investigational Site, Kawasaki, Kanagawa

1245.52.018 Boehringer Ingelheim Investigational Site, Kita-adachi-gun, Saitama

1245.52.022 Boehringer Ingelheim Investigational Site, Kita-ku, Tokyo

1245.52.052 Boehringer Ingelheim Investigational Site, Kitakyushu, Fukuoka

1245.52.076 Boehringer Ingelheim Investigational Site, Kobe, Hyogo

1245.52.026 Boehringer Ingelheim Investigational Site, Kodaira, Tokyo

1245.52.069 Boehringer Ingelheim Investigational Site, Koriyama, Fukushima

1245.52.071 Boehringer Ingelheim Investigational Site, Koriyama, Fukushima

1245.52.014 Boehringer Ingelheim Investigational Site, Koshigaya, Saitama

1245.52.074 Boehringer Ingelheim Investigational Site, Kuki, Saitama

1245.52.055 Boehringer Ingelheim Investigational Site, Kumamoto, Kumamoto

1245.52.049 Boehringer Ingelheim Investigational Site, Kure, Hiroshima

1245.52.040 Boehringer Ingelheim Investigational Site, Kyoto, Kyoto

1245.52.010 Boehringer Ingelheim Investigational Site, Maebashi, Gunma

1245.52.080 Boehringer Ingelheim Investigational Site, Maebashi, Gunma

1245.52.050 Boehringer Ingelheim Investigational Site, Matsuyama, Ehime

1245.52.075 Boehringer Ingelheim Investigational Site, Meguro-ku, Tokyo

1245.52.056 Boehringer Ingelheim Investigational Site, Miyazaki, Miyazaki

1245.52.057 Boehringer Ingelheim Investigational Site, Miyazaki, Miyazaki

1245.52.079 Boehringer Ingelheim Investigational Site, Morioka, Iwate

1245.52.003 Boehringer Ingelheim Investigational Site, Nagoya, Aichi

1245.52.004 Boehringer Ingelheim Investigational Site, Nagoya, Aichi

1245.52.005 Boehringer Ingelheim Investigational Site, Nagoya, Aichi

1245.52.038 Boehringer Ingelheim Investigational Site, Nagoya, Aichi

1245.52.059 Boehringer Ingelheim Investigational Site, Naha, Okinawa

1245.52.066 Boehringer Ingelheim Investigational Site, Naha, Okinawa

1245.52.065 Boehringer Ingelheim Investigational Site, Nanjyo, Okinawa

1245.52.007 Boehringer Ingelheim Investigational Site, Oita, Oita

1245.52.053 Boehringer Ingelheim Investigational Site, Okawa, Fukuoka

1245.52.068 Boehringer Ingelheim Investigational Site, Okinawa, Okinawa

1245.52.042 Boehringer Ingelheim Investigational Site, Osaka,Osaka

1245.52.089 Boehringer Ingelheim Investigational Site, Osaki, Miyagi

1245.52.024 Boehringer Ingelheim Investigational Site, Ota-ku, Tokyo

1245.52.054 Boehringer Ingelheim Investigational Site, Saga, Saga

1245.52.032 Boehringer Ingelheim Investigational Site, Sagamihara, Kanagawa

1245.52.085 Boehringer Ingelheim Investigational Site, Sagamihara, Kanagawa

1245.52.013 Boehringer Ingelheim Investigational Site, Saitama, Saitama

1245.52.015 Boehringer Ingelheim Investigational Site, Sakado, Saitama

1245.52.044 Boehringer Ingelheim Investigational Site, Sakai, Osaka

1245.52.035 Boehringer Ingelheim Investigational Site, Saku, Nagano

1245.52.009 Boehringer Ingelheim Investigational Site, Sapporo, Hokkaido

1245.52.025 Boehringer Ingelheim Investigational Site, Setagaya-ku, Tokyo

1245.52.063 Boehringer Ingelheim Investigational Site, Shimajiri-gun, Okinawa

1245.52.064 Boehringer Ingelheim Investigational Site, Shimajiri-gun, Okinawa

1245.52.001 Boehringer Ingelheim Investigational Site, Shinjuku-ku. Tokyo

1245.52.036 Boehringer Ingelheim Investigational Site, Shizuoka, Shizuoka

1245.52.006 Boehringer Ingelheim Investigational Site, Suita, Osaka

1245.52.043 Boehringer Ingelheim Investigational Site, Takatsuki, Osaka

1245.52.017 Boehringer Ingelheim Investigational Site, Tokorozawa, Saitama

1245.52.070 Boehringer Ingelheim Investigational Site, Tokorozawa, Saitama

1245.52.061 Boehringer Ingelheim Investigational Site, Tomigusuku, Okinawa

1245.52.062 Boehringer Ingelheim Investigational Site, Tomigusuku, Okinawa

1245.52.041 Boehringer Ingelheim Investigational Site, Uji, Kyoto

1245.52.067 Boehringer Ingelheim Investigational Site, Uruma, Okinawa

1245.52.028 Boehringer Ingelheim Investigational Site, Yokohama, Kanagawa

1245.52.029 Boehringer Ingelheim Investigational Site, Yokohama, Kanagawa

1245.52.030 Boehringer Ingelheim Investigational Site, Yokohama, Kanagawa

1245.52.081 Boehringer Ingelheim Investigational Site, Yokohama, Kanagawa

1245.52.082 Boehringer Ingelheim Investigational Site, Yokohama, Kanagawa

1245.52.083 Boehringer Ingelheim Investigational Site, Yokohama, Kanagawa

1245.52.084 Boehringer Ingelheim Investigational Site, Yokohama, Kanagawa

Sponsors
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Boehringer Ingelheim

INDUSTRY